RxDoctor Payments Data

Gerald Aggrey, MD

Adult Reconstructive Orthopaedic Surgery · Eugene, ORNPI 1639564065

Payments from drug & device makers

What this record shows

11 manufacturers reported payments, led by Stryker at 49.1% of the total. Reporting peaked in 2024 at $3,367 and has fallen 82.9% since, to $577 in 2025. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in OR, where the typical reported total is $9,533.

$8,717in general payments, 2019–2025

Across 63 payments — averaging $138.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$4K
  • Zimmer Biomet$4K
  • Orthalign Inc$240
  • Johnson & Johnson$218
  • Onkos Surgical, Inc.$113
  • Wildwood Medical LLC$71
  • plus $175 from 5 others

What the payments were for

  • Travel & lodging$4,21248%
  • Food & beverage$4,50452%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,717 in reported general payments places this provider in the 45th percentile of 20 adult reconstructive orthopaedic surgery providers in Oregon.

See all adult reconstructive orthopaedic surgery providers in Oregon

Medicare billing

Part B allowed, 2024
$101,543
Medicare patients
265
Services billed
948

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam266$933
Diclofenac Sodium25$497
Oxycodone Hcl42$372
Ondansetron OdtOndansetron38$334
Mupirocin20$172
Celecoxib16$139
Tramadol Hcl31$87
Prednisone20$35

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Eugene

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →